Sesame vs LillyDirect for Cash-Pay Zepbound: Which Is Cheapest?

Two of the most-asked cash-pay routes for Zepbound in 2026 are Lilly's own Self Pay Journey Program through LillyDirect Pharmacy^[1] and the Sesame Care direct-pay marketplace^[3]. They are not actually the same kind of service: LillyDirect is a manufacturer-owned dispensing channel with fixed dose-tier pricing, while Sesame is a cash-pay telehealth marketplace where the visit and the medication are billed separately. We mapped each program live on 2026-05-29 and pulled the verbatim prices, eligibility rules, shipping windows, and refill cadence so you can pick the route that matches your situation.

The honest summary

• LillyDirect Self Pay Journey Program is $299 / $399 / $449 per month for KwikPen by dose tier (2.5 mg / 5 mg / 7.5 mg+)^[1]. It is the lowest-friction route if you are commercially uninsured or have a plan that does not cover Zepbound, you are willing to use the KwikPen format, and you want predictable manufacturer-direct pricing.
• Sesame Care is a marketplace where you pay a per-visit fee for the prescriber (typically $30–$99 for an initial weight-loss consultation, with ongoing follow-ups in the same range) and the medication is billed separately at whichever cash channel your prescriber routes you through^[3]. Sesame's most-cited deal is the Costco Member Prescription Program at $349/month for Wegovy and Ozempic^[4]; for Zepbound the patient typically ends up paying LillyDirect's tier price plus the Sesame visit fee.
• NovoCare Wegovy is the comparable first-party Novo Nordisk channel at $349/month standard, with a new-patient intro of $199/month for the first 2 monthly fills on 0.25 mg and 0.5 mg through 2026-06-30^[5]. It is the right comparison for patients who specifically want semaglutide rather than tirzepatide.
• Eligibility is the deciding constraint. The Lilly Self Pay Journey Program is restricted to self-paying cash patients who are not seeking insurance reimbursement, are 18+, and reside in the U.S. or Puerto Rico^[1]. Sesame has no such restriction because the visit and the medication are unbundled.

LillyDirect Self Pay Journey Program: verified pricing and rules

The Self Pay Journey Program is Eli Lilly's manufacturer-direct cash-pay channel for Zepbound, fulfilled through LillyDirect Pharmacy^[2]. The zepbound.lilly.com/savings page we verified on July 2026 lists the following monthly KwikPen pricing tiers^[1]:

• 2.5 mg KwikPen: $299 per month (one 4-pen carton).
• 5 mg KwikPen: $399 per month.
• 7.5 mg KwikPen: $449 per month.
• 10 mg, 12.5 mg, 15 mg KwikPen: $449 per month each. The price does not climb above the 7.5 mg tier, which makes the program substantially cheaper at maintenance doses than the retail pen list price.

Eligibility, verbatim from the savings page: the patient must be 18 or older, reside in the U.S. or Puerto Rico, have a Zepbound prescription for an FDA-approved use consistent with the product label, be paying cash (no insurance reimbursement), and not be a federal-program beneficiary (Medicare, Medicaid, TRICARE, VA, etc.). The refill cadence is capped: a refill must be completed within 45 days of the previous delivery date^[1]. That window is the program's built-in adherence guardrail and the single operational rule that most often catches patients off guard.

Shipping is via LillyDirect Pharmacy's own cold-chain couriers; the program ships nationwide on a multi-day window and requires an adult signature for delivery^[2]. Telehealth is not bundled into the program. Patients arrive at LillyDirect with a prescription from any independent clinician; Lilly maintains a referral list of independent telehealth practices but does not employ those clinicians.

Sesame Care: how the marketplace bills you

Sesame Care is a direct-pay telehealth marketplace that lists independent clinicians offering per-visit prices for primary care, mental health, dermatology, and weight management among other specialties^[3]. The marketplace covers all 50 states through participating clinicians and accepts no commercial insurance — every transaction is cash.

The Sesame weight-loss flow we mapped on 2026-05-29:

• Initial weight-loss visit: typically $30 to $99 depending on the clinician selected, with most asynchronous-message visits at the lower end and synchronous video visits at the higher end^[3].
• Follow-up visits: typically $30 to $99, required at the frequency the prescriber sets (usually monthly during titration, then quarterly at maintenance).
• Medication billing: separate. Sesame does not stock or dispense Zepbound. The prescriber writes a script and the patient routes it to the cash-pay channel of their choice — LillyDirect ($299–$449 by dose tier^[1]), retail pharmacy with manufacturer coupon, or a 503A compounding pharmacy if patient-specific medical-necessity criteria are met^[3].
• Wegovy promotional pricing: Sesame has historically run a $199 / 2-month introductory Wegovy starter for new patients on the lower doses, which tracks NovoCare's own intro offer^[5].
• Costco Member Prescription Program: Sesame operates the prescriber side of the Costco CMPP weight-loss program, which advertises Wegovy and Ozempic at $349/month to Costco members^[4]. The CMPP discount is only available to active Costco members and is not eligible for insurance reimbursement.

The implication for cash-pay Zepbound specifically: choosing Sesame is mostly a choice about the visit experience, not the medication price. The medication price ends up being LillyDirect's tier price in nearly every Sesame Zepbound flow, because LillyDirect is the cheapest first-party Zepbound channel and Sesame prescribers route there by default.

Side-by-side comparison axes

• Per-month cash cost at maintenance (5 mg+). LillyDirect alone: $399–$449 (medication only, visit cost separate from your prescriber^[1]). Sesame + LillyDirect: $399–$449 medication plus $30–$99 visit fee on the visit cadence the prescriber sets^[3].
• Promotional pricing. LillyDirect does not publish a first-month discount. Sesame and NovoCare both carry intro-month pricing for Wegovy (not Zepbound) and Costco CMPP carries the $349/month membership tier for Wegovy and Ozempic (not Zepbound)^[4].
• Eligibility. LillyDirect: cash-pay only, 18+, U.S. or Puerto Rico, no federal-program beneficiaries^[1]. Sesame: any U.S. resident the clinician will see; no insurance status check because there is no insurance involved.
• Format. LillyDirect Self Pay Journey is currently KwikPen-based at every dose. Vials are also available through LillyDirect under separate program rules for selected dose strengths. Auto-injector pens remain available through retail pharmacy at non-program list prices.
• Refill cadence. LillyDirect: a refill must be processed within 45 days of the previous shipment to maintain program pricing^[1]. Sesame: refill cadence is whatever the prescriber sets; medication channel determines its own rules.
• Telehealth visit requirements. LillyDirect does not require synchronous video; the program accepts any valid prescription. Sesame visits are asynchronous-message or synchronous-video at the clinician's discretion.
• Shipping reliability. LillyDirect ships from Lilly's own cold-chain network with adult-signature requirement and same-day status updates. Sesame does not ship medications; the medication channel handles shipping.
• Script portability. Both routes produce a standard prescription that can be transferred to a retail pharmacy at any time; the patient simply loses the program pricing on subsequent fills.

Annual cost at maintenance: what the math actually looks like

Patient-fit matrix

Pick LillyDirect Self Pay Journey Program if: you already have a clinician who will write the prescription, you are committed to Zepbound specifically and want predictable manufacturer-direct pricing, you are commercially uninsured or your plan does not cover Zepbound, and you can meet the 45-day refill cadence^[1]. Lilly's vials and KwikPens are produced and shipped from the same FDA-regulated manufacturing chain as retail Zepbound; bioequivalence is not in question because they are the identical drug product.

Pick Sesame Care if: you do not yet have a prescriber, you want a one-stop intake flow that handles clinician selection plus prescription routing in the same visit, you appreciate the cross-specialty marketplace (your Sesame account can also see a PCP, dermatologist, or mental-health clinician), or you want the Wegovy-specific Costco CMPP $349 deal^[4]. Recognize that for Zepbound the medication itself still flows through LillyDirect at the tier price; the Sesame visit fee is incremental.

Pick NovoCare Wegovy if: you prefer semaglutide over tirzepatide (clinically appropriate for many patients, especially those who want the SELECT cardiovascular indication or the MASH evidence base), you want the $199/2-month intro^[5], or you want a single flat-price program that does not vary by dose. SURMOUNT-1 magnitude on tirzepatide is larger than STEP-1 on semaglutide ^[7], but the absolute difference is not the primary driver for most patients picking between programs; cost, format, and side-effect tolerability are.

Trade-offs the cash-pay routes share

Every cash-pay route in 2026 carries the same three structural limits. First, the program prices are not eligible for HSA or FSA reimbursement if the receipt does not clearly identify the medication as a covered prescription expense — both LillyDirect and Sesame issue itemized receipts that satisfy most HSA/FSA administrators, but verify with your plan before you assume eligibility. Second, the cash-pay route does not accrue toward your annual insurance out-of-pocket maximum; switching back to an insurance fill mid-year can reset your deductible math. Third, FDA-approved Zepbound supply chain capacity is finite; in late 2024 and early 2025 the tirzepatide shortage caused fulfillment delays on both LillyDirect and retail. Tirzepatide came off the shortage list in October 2024 and stayed off after the OFA-v-FDA litigation resolved in March 2025, so 2026 fulfillment delays are unusual but not impossible (see our compounded-tirzepatide current-status article for the regulatory timeline).

What to do if you are switching from compounded

A common 2026 flow is the switch from a 503A-compounded tirzepatide subscription to LillyDirect Self Pay Journey Program. The compounding pathway narrowed sharply after the March 2025 enforcement deadline — non-patient-specific 503B production of tirzepatide is no longer permitted, and 503A patient-specific scripts require documented medical necessity rather than the off-the-shelf wellness model that dominated 2023–2024 (timeline here). Patients switching from compounded to LillyDirect should expect: dose-equivalence is the same active ingredient at the same milligram, so titration history transfers; the cost difference is roughly $100–$200/month higher at the 5 mg tier; the 45-day refill cadence is stricter than most compounded subscriptions; the side-effect profile is the same because the active is identical.

For an evidence walkthrough of the format change, see our decision guide on compounded vs branded GLP-1 . For raw pricing across every channel including LillyDirect, Sesame, NovoCare, Costco, Sam's Club, and Amazon, see our cash-pay coupon and channel guide .

The disambiguation question patients keep asking

Sesame and LillyDirect are sometimes described as partners. That description is imprecise. Lilly does not have an exclusive partnership with Sesame the way Novo Nordisk has a loose partnership with NovoCare; LillyDirect operates as Lilly's own dispensing arm and accepts prescriptions from any clinician with U.S. prescribing authority — Sesame, Form Health, 9amHealth, Ro, Hims, an independent endocrinologist, your primary-care doctor, anyone. What Sesame offers in the Zepbound flow is the visit; what LillyDirect offers is the dispensing. Picking the two together is a perfectly reasonable workflow and produces the LillyDirect tier price for the medication plus the Sesame visit fee for the clinician.

Bottom line

For cash-pay Zepbound specifically, LillyDirect Self Pay Journey Program is the cheapest tier-priced channel at $299 / $399 / $449 per month by dose^[1], and most Sesame Zepbound flows route to LillyDirect anyway for the medication. Sesame is the better entry point if you do not yet have a prescriber and want a one-stop telehealth flow, especially if you also want access to other specialties on the marketplace. For semaglutide rather than tirzepatide, NovoCare Wegovy at $349/month standard with the $199/2-month intro is the comparable first-party channel^[5]. All three routes verified live July 2026.